SCHEMBL5090699

SCHEMBL5090699

COc1[c]cc(Br)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALOX5 P09917 1/20 0.36
PTGS2 P35354 1/20 0.36
HTR2A P28223 8/20 0.36
HTR2C P28335 3/20 0.36
TAAR1 Q96RJ0 3/20 0.36
HTR2B P41595 1/20 0.36
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
PRKDC P78527 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11358289 0.83 POLB (0.39) POLBL3MBTL1GRIN2DGRIN3BGRIN1
SCHEMBL592705 0.79 CYP3A4 (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL221777 0.78 CA2 (0.35) POLBL3MBTL1MAPTNPSR1CA2
SCHEMBL26185927 0.77 ALOX5 (0.44) POLBL3MBTL1GRIN2DGRIN3BGRIN1
SCHEMBL28821414 0.77 POLB (0.38) POLBL3MBTL1GRIN2DGRIN3BGRIN1
SCHEMBL1637863 0.76 ACHE (0.39) MAPTPTGS2TAAR1
SCHEMBL358784 0.74 GAA (0.42) MAPTNPSR1TAAR1APOBEC3G
SCHEMBL7255898 0.74 ACHE (0.33) MAPTPTGS2HTR2AHTR2CHTR2B
SCHEMBL3989267 0.72 CA2 (0.34) CA2CA4
SCHEMBL6683483 0.72 CA2 (0.34) CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108135175-B Bicyclic compounds and their use for inhibition of SUV39H2 肿瘤疗法科学股份有限公司 2021-04-06 CN disclosed
US-20080015190-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed
EP-0510440-B1 Positive-working radiation-sensitive composition and radiation-sensitive recording material produced therewith CLARIANT GMBH (DE) 1999-01-13 EP disclosed
EP-0510449-B1 Acid-cleavable compounds, positive-working radiation-sensitive composition containing the same and radiation-sensitive recording material prepared therefrom CLARIANT GMBH (DE) 1998-08-05 EP disclosed
EP-0510443-B1 Negative-working radiation-sensitive composition and radiation-sensitive recording material produced therewith HOECHST AG (DE) 1995-03-22 EP disclosed
US-5286867-A Substituted 1-sulfonyloxy-2-pyridones and process for preparing them HOECHST AKTIENGESELLSCHAFT (DE) 1994-02-15 US disclosed
US-5286602-A Acid-cleavable compounds, positive-working radiation-sensitive mixture containing these compounds, and radiation-sensitive recording material produced with this mixture HOECHST AKTIENGESELLSCHAFT (DE) 1994-02-15 US disclosed
US-5230985-A NEGATIVE-WORKING RADIATION-SENSITIVE MIXTURES, AND RADIATION-SENSITIVE RECORDING MATERIAL PRODUCED WITH THESE MIXTURES HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-27 US disclosed
US-5229254-A Photoresists, printing plates, sulfonic acid generators HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-20 US disclosed
EP-0510442-A1 Substituted 1-sulfonyloxy-2-pyridones, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-28 EP disclosed
EP-0510443-A1 Negative-working radiation-sensitive composition and radiation-sensitive recording material produced therewith HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-28 EP disclosed
EP-0510440-A1 Positive-working radiation-sensitive composition and radiation-sensitive recording material produced therewith HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-28 EP disclosed
EP-0510449-A2 Acid-cleavable compounds, positive-working radiation-sensitive composition containing the same and radiation-sensitive recording material prepared therefrom HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-28 EP disclosed
EP-0363527-A1 Photographic element comprising benzoxazine or benzothiazine derivatives AGFA-GEVAERT N.V. (BE) 1990-04-18 EP disclosed
US-4766213-A 1,4-dihydropyridines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1988-08-23 US disclosed
EP-0237695-A2 1,4-Dihydropyridines MERCK PATENT GmbH (DE) 1987-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015190-A1 Inhibitors of Histone Deacetylase HDAC5, HDAC1, HDAC4 POLB 951/4885L3MBTL1 2632/4885GRIN2D 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.